Rubius is advancing its new class of cellular medicines called Red Cell Therapeutics (RCTs) — red blood cells engineered to express biotherapeutic proteins within or on their cell surface to create highly selective, potent, and allogeneic cellular therapies . . .
Home Autoimmune Disorders A Ruby in the Rough: Rubius Therapeutics Transforms Red Blood Cells into...
A Ruby in the Rough: Rubius Therapeutics Transforms Red Blood Cells into Cellular Medicines
CEO Pablo Cagnoni shares how the company manufactures genetically engineered red blood cells to eliminate cancer and treat autoimmune diseases.
Rubius Therapeutics is advancing its new class of cellular medicines called Red Cell Therapeutics (RCTs) — red blood cells engineered to express biotherapeutic proteins within or on their cell surface to create highly selective, potent, and allogeneic cellular therapies.[Rubius Therapeutics]